152 related articles for article (PubMed ID: 2175179)
1. Effects of herbimycin A and various SH-reagents on p60v-src kinase activity in vitro.
Fukazawa H; Mizuno S; Uehara Y
Biochem Biophys Res Commun; 1990 Nov; 173(1):276-82. PubMed ID: 2175179
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.
Fukazawa H; Li PM; Yamamoto C; Murakami Y; Mizuno S; Uehara Y
Biochem Pharmacol; 1991 Oct; 42(9):1661-71. PubMed ID: 1656993
[TBL] [Abstract][Full Text] [Related]
3. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.
Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T
FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836
[TBL] [Abstract][Full Text] [Related]
4. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
[TBL] [Abstract][Full Text] [Related]
5. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds.
Uehara Y; Fukazawa H; Murakami Y; Mizuno S
Biochem Biophys Res Commun; 1989 Sep; 163(2):803-9. PubMed ID: 2783121
[TBL] [Abstract][Full Text] [Related]
6. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
Uehara Y; Fukazawa H
Methods Enzymol; 1991; 201():370-9. PubMed ID: 1658554
[No Abstract] [Full Text] [Related]
7. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system.
Hamaguchi M; Matsuyoshi N; Ohnishi Y; Gotoh B; Takeichi M; Nagai Y
EMBO J; 1993 Jan; 12(1):307-14. PubMed ID: 8381351
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
[TBL] [Abstract][Full Text] [Related]
9. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
[TBL] [Abstract][Full Text] [Related]
10. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
[TBL] [Abstract][Full Text] [Related]
11. Effects of herbimycin derivatives on src oncogene function in relation to antitumor activity.
Uehara Y; Murakami Y; Suzukake-Tsuchiya K; Moriya Y; Sano H; Shibata K; Omura S
J Antibiot (Tokyo); 1988 Jun; 41(6):831-4. PubMed ID: 3403381
[No Abstract] [Full Text] [Related]
12. Evidence for autoinhibitory regulation of the c-src gene product. A possible interaction between the src homology 2 domain and autophosphorylation site.
Fukami Y; Sato K; Ikeda K; Kamisango K; Koizumi K; Matsuno T
J Biol Chem; 1993 Jan; 268(2):1132-40. PubMed ID: 7678249
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG
Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
[TBL] [Abstract][Full Text] [Related]
14. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
[TBL] [Abstract][Full Text] [Related]
15. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase.
Oo ML; Senga T; Thant AA; Amin AR; Huang P; Mon NN; Hamaguchi M
Oncogene; 2003 Mar; 22(9):1411-7. PubMed ID: 12618767
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A.
Uehara Y; Murakami Y; Mizuno S; Kawai S
Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516
[TBL] [Abstract][Full Text] [Related]
17. Induction by herbimycin A of contact inhibition in v-src-expressed cells.
Suzukake-Tsuchiya K; Moriya Y; Hori M; Uehara Y; Takeuchi T
J Antibiot (Tokyo); 1989 Dec; 42(12):1831-7. PubMed ID: 2559910
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in mice bearing BCR/ABL-transfected cells.
Okabe M; Uehara Y; Noshima T; Itaya T; Kunieda Y; Kurosawa M
Leuk Res; 1994 Nov; 18(11):867-73. PubMed ID: 7967714
[TBL] [Abstract][Full Text] [Related]
19. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts.
Matsuyoshi N; Hamaguchi M; Taniguchi S; Nagafuchi A; Tsukita S; Takeichi M
J Cell Biol; 1992 Aug; 118(3):703-14. PubMed ID: 1639852
[TBL] [Abstract][Full Text] [Related]
20. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.
Yoneda T; Lowe C; Lee CH; Gutierrez G; Niewolna M; Williams PJ; Izbicka E; Uehara Y; Mundy GR
J Clin Invest; 1993 Jun; 91(6):2791-5. PubMed ID: 8514886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
